Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|November 17, 2022
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseasesLi Jiao, Shougang GuoJournal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|March 30, 2007
Effects of minimally invasive puncture and drainage of intracranial hematoma on the blood-brain barrier in patients with cerebral hemorrhageXiaojiang Huang, Shougang Guo, Wei WangFrontiers in Neurology|April 30, 2021
Afterdischarges in Myasthenia GravisLi Yang, Shougang Guo, Xiuying ChenJournal of Neuroimmunology|November 25, 2021
Eculizumab treatment for myasthenia gravis subgroups: 2021 updateLi Jiao, Honghao Li, Shougang GuoThe Journal of Biological Chemistry|November 23, 2023
Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1/Wnt pathwayDanqing Qin, Chunjuan Wang, Dong Li, et al.Scientific Reports|January 21, 2017
Altered motion repulsion in Alzheimer's diseaseYan Li, Shougang Guo, Yongxiang Wang, et al.Frontiers in Immunology|February 21, 2025
Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature reviewJingliang Zhang, Minzhe Hu, Chunjuan Wang, et al.International Immunopharmacology|August 19, 2017
Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cellsYawei Hu, Ziling Zeng, Baojie Wang, et al.Zhonghua Yi Xue Za Zhi|January 28, 2016
[Effect of LINGO-1 gene silencing on movement function of EAE mice]Shougang Guo, Jie Zhang, Chunjuan Wang, et al.Journal of Neurochemistry|April 25, 2023
Ferroptosis and central nervous system demyelinating diseasesDanqing Qin, Dong Li, Chunjuan Wang, et al.Pageof 7